Anaptysbio (ANAB) Interest & Investment Income (2017 - 2026)
Anaptysbio posted quarterly Interest & Investment Income of $2.7 million for Q1 2026, down 39.88% year-on-year from $4.4 million in Q1 2025, and up 5.78% on a QoQ basis from $2.5 million in Q4 2025.
Anaptysbio (ANAB) has 10 years of Interest & Investment Income data on file, last reported at $2.7 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 39.88% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $11.7 million (down 40.18% YoY), and the FY2025 full-year result was $13.5 million, down 31.8% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.7 million, up from $2.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.3 million in Q3 2024 and bottomed at $342000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $4.4 million (2025), against an average of $3.7 million.
- The widest annual swing landed in 2022, when Interest & Investment Income surged 5545.59%; it then plunged 52.35% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $3.8 million in 2022, then gained by 27.12% to $4.9 million in 2023, then increased by 7.85% to $5.3 million in 2024, then slumped by 52.35% to $2.5 million in 2025, then gained by 5.78% to $2.7 million in 2026.
- The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $2.5 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.92 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 4.58 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.85 Mn |
| Jun 30, 2023 | 4.65 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 3.84 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 342,000.00 |
| Dec 31, 2021 | 68,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 104,000.00 |
| Mar 31, 2021 | 195,000.00 |
| Dec 31, 2020 | 376,000.00 |
| Sep 30, 2020 | 625,000.00 |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 1.90 Mn |
| Dec 31, 2019 | 2.28 Mn |
| Sep 30, 2019 | 2.76 Mn |
| Jun 30, 2019 | 2.96 Mn |
| Mar 31, 2019 | 2.99 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Sep 30, 2018 | 1.37 Mn |
| Jun 30, 2018 | 1.30 Mn |
| Mar 31, 2018 | 1.19 Mn |
| Dec 31, 2017 | 861,000.00 |
| Sep 30, 2017 | 358,000.00 |
| Jun 30, 2017 | 281,000.00 |
| Mar 31, 2017 | 122,000.00 |